- ￥1700 - 4000
- GeneTex
- 美国
- GTX638878
- 2025年07月11日
- WB
- Rabbit
企业认证
相关产品推荐更多 >
![HSDL2 antibody [2A11BG6AH6]](https://img1.dxycdn.com/2022/0328/365/2092002952650400453-14.jpg!wh200)
![Calnexin antibody [HL1598]](https://img1.dxycdn.com/2023/0605/631/4015123267601755661-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant fragment of Japanese encephalitis virus Envelope
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Japanese encephalitis virus
- 目录编号：
GTX638878
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Rabbit
- 应用范围：
WB
- 浓度：
1 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
This antibody is specific for JEV Envelope protein, and it does not cross-react with Zika, DENV-1, DENV-2, DENV-3, and DENV-4 Envelope protein.
- 抗体英文名：
Japanese encephalitis virus Envelope antibody [HL2517]
- 抗体名：
Japanese encephalitis virus Envelope 抗体 [HL2517]
- 规格：
100 μl/25 μl
| 规格： | 100 μl | 产品价格： | ￥4000.0 |
|---|---|---|---|
| 规格： | 25 μl | 产品价格： | ￥1700.0 |
Non-infected (–) and infected (+) BHK-21 whole cell extracts were separated by 12% SDS-PAGE, and the membrane was blotted with Japanese encephalitis virus Envelope antibody [HL2517] (GTX638878) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Manipulation of Vaccinia Virus Vectors
of vaccinia virus as a vector owes much to the ease of generating recombinants, the authenticity of the foreign gene product, and the wide variety of uses to which they have been put. For example, HIV 1 (human immunodeficiency virus) envelope glycoprotein
Preparation of Recombinant Viral Glycoproteins for Novel and Therapeutic Antibody Discovery
of virus neutralization, and in the eventual development of specific entry inhibitors, vaccines, and research tools. The majority of the more recently developed antiviral hmAbs have come from the use of antibody phage-display technologies using both na�ve
Sindbis Virus-Based Vectors for the Study of Class I Antigen Presentation In Vitro and In Vivo
, and ability to express large amounts of protein (13 ). Several members of the Alphavirus genus, including Sindbis virus (SIN), Semliki Forest virus, and Venezuelan equine encephalitis virus, have been modified genetically for use as viral expression vectors
技术资料暂无技术资料 索取技术资料
